Advertisement

The Impact of Infection During Pregnancy on the Mother and Baby

  • Heather E. Jeffery
  • Monica M. Lahra

Infection continues to account for a major proportion of maternal, fetal, and neonatal mortality and morbidity worldwide.

In the developing world, maternal systemic infections, such as pneumonia, malaria, tuberculosis, typhoid fever, and pyelonephritis, which are often functions of poverty, crowding, and malnutrition, impose health costs to the mother and risks to the fetus. These risks include spontaneous abortion, stillbirth, preterm labor and preterm birth, low birth weight, intrauterine growth restriction (IUGR), and infection. This is in addition to the rapidly escalating rates of a number of sexually transmitted diseases, in particular, human immunodeficiency virus (HIV) infection with its associated comorbidities.

Keywords

Preterm Birth Sexually Transmitted Infection Bacterial Vaginosis Genital Herpes Congenital Toxoplasmosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmad N (2005) The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus. Crit Rev Clin Lab Sci 42:1–34.PubMedCrossRefGoogle Scholar
  2. American Academy of Pediatrics (2003a) Cytomegalo-virus infection. In: Pickering LK (ed) Red Book Online 2003: Report of the Committee on Infectious Diseases, 26th ed. American Academy of Pediatrics, Elk Grove Village, IL, pp. 259–262. http:// aapredbook.aappublications.org/.Google Scholar
  3. American Academy of Pediatrics (2003b) Herpes simplex. In: Pickering LK (ed) Red Book Online 2003: Report of the Committee on Infectious Diseases, 26th ed. American Academy of Pediatrics, Elk Grove Village, IL, pp. 344–353. http://aapredbook. aappublications.org/.Google Scholar
  4. American Academy of Pediatrics (2003c) Human Immunodeficiency Virus. In: Pickering LK (ed) Red Book Online 2003: Report of the Committee on Infectious Diseases, 26th ed. American Academy of Pediatrics, Elk Grove Village, IL, pp. 360–382. http:// aapredbook.aappublications.org/.Google Scholar
  5. American Academy of Pediatrics (2003d) Varicella-zoster infection. In: Pickering LK (ed) Red Book Online 2003: Report of the Committee on Infectious Diseases, 26th ed. American Academy of Pediatrics, Elk Grove Village, IL, pp. 672–686. http:// aapredbook.aappublications.org/.Google Scholar
  6. Anderson MJ, Higgins PG, Davis LR, et al. (1985) Experimental parvoviral infection in humans. J Infect Dis 152:257–65PubMedGoogle Scholar
  7. Arias F, Tomich P (1982) Etiology and outcomes of low birth weight and preterm infants. Obstet Gynecol 60:277–281.PubMedGoogle Scholar
  8. Arvin AM (1996) Varicella-zoster virus. Clin Microbiol Rev 9:361–381.PubMedGoogle Scholar
  9. Arvin AM, Hensliegh PA, Prober CG, et al. (1986) Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex at delivery. N Engl J Med 315:796–800.PubMedGoogle Scholar
  10. Austin N, Darlow B (2003) Prophylactic oral antifungal agents to prevent systematic Candida infection in preterm infants. Cochrane Database of Systematic Reviews 4:CD003478.Google Scholar
  11. Bachman J, Heise R, Naessons J, et al. (1993) A study of various tests to detect asymptomatic urinary tract infections in an obstetric population. JAMA 270: 1971–1974.PubMedCrossRefGoogle Scholar
  12. Baker C, Edwards M (2003) Group B streptococcal conjugate vaccines. Arch Dis Child 88:375–378.PubMedCrossRefGoogle Scholar
  13. Banatvala JE, Brown DWG (2004) Rubella. Lancet 363:1127–1137.PubMedCrossRefGoogle Scholar
  14. Benitz W, Gould J, Druzin M (1999) Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 103. URL: http://www.pediatrics.org/cgi/content/full/ 103/6/e77.
  15. Berkowitz K, LaSala A (1990) Risk factors associated with the increasing prevalence of pneumonia during pregnancy. Am J Obstet Gynecol 163:981–985.PubMedGoogle Scholar
  16. Berman S (2004) Maternal syphilis: pathophysiology and treatment. Bull WHO 82:433–438.PubMedGoogle Scholar
  17. Bignell CJ (2001) European guidelines for the management of gonorrhea. Int J STD AIDS 12(suppl 12): 27–29.PubMedCrossRefGoogle Scholar
  18. Bisharat N, Crook D, Leigh J, et al. (2004) Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol 42:2161–2167.PubMedCrossRefGoogle Scholar
  19. Blackwell AL (1999) Vaginal bacterial phaginosis? Sex Transm Inf 75:352–353.CrossRefGoogle Scholar
  20. Boyer K, Gotoff S (1986) Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 314: 1665–1669.PubMedGoogle Scholar
  21. Brabin B, Romagosa C, Abdelgalil S, et al. (2004) The sick placenta—the role of malaria. Placenta 25:359– 378.PubMedCrossRefGoogle Scholar
  22. Bradshaw C, Morton A, Garland S, et al. (2005) Higher-risk behavioural practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 106:105–114.PubMedGoogle Scholar
  23. Brocklehurst P (1999) Update on the treatment of sexually transmitted infections in pregnancy-1. Int J STD AIDS 10:571–580.PubMedCrossRefGoogle Scholar
  24. Brocklehurst P (2002) Antibiotics for gonorrhoea in pregnancy. Cochrane Database of Systematic Reviews 2:CD000098.Google Scholar
  25. Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117.PubMedCrossRefGoogle Scholar
  26. Brown KE, Green SW, Antunez de Mayolo J, et al. (1994) Congenital anemia after transplacental parvovirus B19 infection. Lancet 343:895–896.PubMedCrossRefGoogle Scholar
  27. Brown ZA, Benedetti J, Ashley R, et al. (1986) Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 315:796–800.Google Scholar
  28. Brown ZA, Wald A, Morrow RA, et al. (2003) Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203–209.PubMedCrossRefGoogle Scholar
  29. Bryce J, Boshi-Pinto C, Shibuya K, et al. (2005) WHO estimates of the causes of death in children. Lancet 365:1147–1152.PubMedCrossRefGoogle Scholar
  30. Carr P, Felsenstein D, Friedman R (1998) Evaluation and management of vaginitis. J Gen Intern Med 13:335–346.PubMedCrossRefGoogle Scholar
  31. Carrol S, Papaioannou S, Ntumazah I, et al. (1996) Lower genital tract swabs in the prediction of intra-uterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 103:54–59.Google Scholar
  32. Cassell G, Davis R, Waites K, et al. (1983) Isolation of Mycoplasma hominis and ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 10(4 suppl):294–302.PubMedGoogle Scholar
  33. Centers for Disease Control and Prevention (1995) Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or peri-natally exposed to human immunodeficiency virus. MMWR 44(RR-4).Google Scholar
  34. Centers for Disease Control and Prevention (1996) Prevention of varicella: recommendations of Advisory Committee on Immunization Practices (ACIP). MMWR 45(RR-11).Google Scholar
  35. Centers for Disease Control and Prevention (1997) Case definitions for Infectious conditions under public health surveillance. MMWR 46(RR-10):30.Google Scholar
  36. Centers for Disease Control and Prevention (2001) Control and prevention of rubella; evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 50(RR-12).Google Scholar
  37. Centers for Disease Control and Prevention (2002a) Prevention of perinatal group B streptococcal disease. MMWR 51(RR-11):1–22.Google Scholar
  38. Centers for Disease Control and Prevention (2002b) Sexually transmitted diseases treatment guidelines 2002. MMWR 51(RR-6):1–84.Google Scholar
  39. Centers for Disease Control and Prevention (2004) Trends in Reportable Sexually Transmitted Diseases in the United States, 2004. National Data on Chla-mydia, Gonorrhea and Syphilis. Atlanta, GA: U.S. Department of Health and Human Services.Google Scholar
  40. Centers for Disease Control and Prevention (2005a) Achievements in public health: elimination of rubella and congenital rubella syndrome in the United States, 1969–2004. MMWR 54;279–282.Google Scholar
  41. Centers for Disease Control and Prevention (2005b) Controlling tuberculosis in the United States. MMWR 54(RR-12):1–81.Google Scholar
  42. Centers for Disease Control and Prevention (2005c) Cytomegalovirus (CMV) infection. http://www.cdc. gov/ncidod/diseases/cmv.htm.
  43. Centers for Disease Control and Prevention (2005d) Early-onset and late-onset neonatal group B strepto-coccal disease- United States, 1996–2004. MMWR 54(RR-47):1205–1208.Google Scholar
  44. Centers for Disease Control and Prevention (2005e) Genital herpes fact sheet. http://www.cdc.gov/std/ Herpes/STDFact-Herpes.htm.
  45. Centers for Disease Control and Prevention (2005f) Human immunodeficiency type 2. http://www.cdc. gov/hiv/pubs/facts/hiv2.htm.
  46. Centers for Disease Control and Prevention (2005g) Parvovirus B19 infection and pregnancy. http://www. cdc.gov/ncidod/dvrd/revb/respiratory/B19&preg. htm.
  47. Centers for Disease Control and Prevention (2005h) Reported Tuberculosis in the United States, 2004. Atlanta, GA: U.S. Department of Health and Human Services.Google Scholar
  48. Centers for Disease Control and Prevention (2005i) STDs and Pregnancy—CDC Fact Sheet. http:// www.cdc.gov/std/STDFact-STDs&Pregnancy.htm (accessed December 6, 2005).
  49. Chaim W, Mazor M, Wiznitzer A (1992) The prevalence and clinical significance of intraamniotic infection with Candida species in women with preterm labour. Arch Gynecol Obstet 251:9–15.PubMedCrossRefGoogle Scholar
  50. Colditz G, Brewer T, Berkley C, et al. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271: 698–702.PubMedCrossRefGoogle Scholar
  51. Cooper LZ, Krugman S (1967) Clinical manifestations of postnatal and congenital rubella. Arch Ophthal-mol 77:343–349.Google Scholar
  52. Corcoran A, Doyle S (2004) Advances in the biology, diagnosis and host-pathogen interactions of parvovi-rus B19. J Med Microbiol 53:459–75.PubMedCrossRefGoogle Scholar
  53. Cossart YE, Field AM, Cant B, Widdows D (1975) Parvovirus-like particles in human sera. Lancet 1:72–73.PubMedCrossRefGoogle Scholar
  54. Cotch M, Pastorek J, Nugent R (1991) Demographic and behavioural predictors of Trichomonas vaginalis infection among pregnant women. The vaginal infections and prematurity study group. Obstet Gynecol 78:1087–92.Google Scholar
  55. Cotch M, Pastorek J, Nugent R (1997) Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 24:353–360.PubMedCrossRefGoogle Scholar
  56. Danesh I, Stephen J, Gorbach J (1995) Neonatal Tricho-monas vaginalis infection. J Emerg Med 13:51–54.PubMedCrossRefGoogle Scholar
  57. Dear K, Andrews R, Holden J, et al. (2003) Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews 4: CD000422.Google Scholar
  58. Demmler GJ (1991) Infectious Diseases Society of America and Centers for Disease Control: summary of a workshop on surveillance for congenital cyto-megalovirus disease. Rev Infect Dis 13;315–29.PubMedGoogle Scholar
  59. DeVillard E, Burton J, Reid G (2005) Complexity of vaginal microflora as analysed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis. Infect Dis Obstet Gynecol 13:25–30.PubMedGoogle Scholar
  60. Donovan B (2004) Sexually transmissible infections other than HIV. Lancet 363:545–556.PubMedCrossRefGoogle Scholar
  61. Duffy PE (2003) Maternal immunization and malaria in pregnancy. Vaccine 21:3358–3361.PubMedCrossRefGoogle Scholar
  62. Dunn D, Wallon M, Peyron F, et al. (1999) Mother-to-child transmission of toxoplasmosis: risk estimated for clinical counselling. Lancet 353:1829–1833.PubMedCrossRefGoogle Scholar
  63. Edwards J, Apicella M (2004) The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Micro Rev 17:965–981.PubMedCrossRefGoogle Scholar
  64. Enders G, Bader U, Lindemann L, et al. (2001) Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 21:362–377.PubMedCrossRefGoogle Scholar
  65. Enders G, Miller E, Craddock-Watson J, et al. (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343:1548–1552.PubMedCrossRefGoogle Scholar
  66. Enright AM, Prober CG (2004) Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus. Pediatr Clin North Am 51:889–908.PubMedCrossRefGoogle Scholar
  67. Fischer PB (2003) Malaria and newborns. J Trop Pediatr 49:132–134.PubMedCrossRefGoogle Scholar
  68. Fleming DT, McQuillan GM, Johnson RE, et al. (1997) Herpes simplex virus type 2 in the United States, 1976–1994. N Engl J Med 337:1105–1111.PubMedCrossRefGoogle Scholar
  69. Fletcher M (2001) Vaccine candidates in STD. Int J STD AIDS 12:419–422.PubMedCrossRefGoogle Scholar
  70. Forrest JM, Turnbull FM, Sholler GF, et al. (2002) Gregg's congenital rubella patients 60 years later. Med J Aust 177:664–667.PubMedGoogle Scholar
  71. Foulon W, Pinon J-M, Stray-Pedersen B, et al. (1999) Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 181:843–847.PubMedCrossRefGoogle Scholar
  72. Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49:53–70.PubMedCrossRefGoogle Scholar
  73. Fraser C, Norris S, Weinstock G (1998) Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375–388.PubMedCrossRefGoogle Scholar
  74. Freedman E, Mindel A, Jones CA (2004) Epidemiologi-cal, clinical and laboratory aids for the diagnosis of neonatal herpes—an Australian perspective. Herpes 11:38–40.PubMedGoogle Scholar
  75. Frieden T, Sterling T, Munsiff S, et al. (2003) Tuberculosis. Lancet 362:887–899.PubMedCrossRefGoogle Scholar
  76. Garner P, Gülmezoglu AM (2002) Drugs for preventing malaria-related illness in pregnant women and death in the newborn. Cochrane Database of Systematic Reviews 4:CD000169.Google Scholar
  77. Gibbs R, Schrag S, Schuchat A (2004) Perinatal infections due to group B streptococci. Obstet Gynecol 104:1062–1076.PubMedGoogle Scholar
  78. Goldenberg R, Andrews W, Mercer B, et al. (2000a) The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth. Am J Obstet Gynecol 182:625–630.CrossRefGoogle Scholar
  79. Goldenberg R, Hauth J, Andrews W (2000b) Intrauter-ine infection and preterm delivery. N Engl J Med 342:1500–1507.CrossRefGoogle Scholar
  80. Grant AD, De Cock KM (2001) ABC of AIDS. HIV infection and AIDS in the developing world. Br Med J 322:1475–1478.Google Scholar
  81. Gregg NM (1941) Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3:35–46.Google Scholar
  82. Griffiths P, Baboonian C, Ashby D (1985) The demographic characteristics of pregnant women infected with cytomegalovirus. Int J Epidemiol 14:447–552.PubMedCrossRefGoogle Scholar
  83. Guerin P, Olliaro P, Nosten F, et al. (2002) Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis 2:564–573.PubMedCrossRefGoogle Scholar
  84. Gülmezoglu AM (2002) Interventions for trichomonia-sis in pregnancy. Cochrane Database of Systematic Reviews 3:CD000220.Google Scholar
  85. Guyatt H, Snow R (2001) Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans Royal Soc Trop Med Hygiene 95: 569–576.CrossRefGoogle Scholar
  86. Guyatt H, Snow R (2004) Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Micro Rev 17:760–769.PubMedCrossRefGoogle Scholar
  87. Haberland C, Benitz W, Sanders G, et al. (2002) Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 110:471–480.PubMedCrossRefGoogle Scholar
  88. Haile M, Kallenius G (2005) Recent developments in tuberculosis vaccines. Curr Opin Infect Dis 18:211– 215.PubMedCrossRefGoogle Scholar
  89. Hedges S, Mayo M, Mestecky J, et al. (1999) Limited local and systemic antibody response to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun 67:3937–3946.PubMedGoogle Scholar
  90. Heegaard ED, Laub Peterson B (2000) Parvovirus B19 transmitted by bone marrow. Br J Haematol 111:659– 661PubMedCrossRefGoogle Scholar
  91. Heine P, McGregor J (1993) Trichomonas vaginalis: a remerging pathogen. Clin Obstet Gynecol 36:137– 144.PubMedCrossRefGoogle Scholar
  92. Hightower M, Kallas EG (2003) Diagnosis, antiretrovi-ral therapy, and emergence of resistance to antiret-roviral agents in HIV-2 infection: a review. Brazi J Inf Dis 7(1):7–15.Google Scholar
  93. Hill J, Roberts S (2005) Herpes simplex virus in pregnancy: New concepts in prevention and management. Clin Perinatol 32:657–670.PubMedCrossRefGoogle Scholar
  94. Hollier LM, Grissom H (2005) Human herpes viruses in pregnancy: cytomegalovirus, Epstein-Barr virus, and varicella zoster virus. Clin Perinatol 32:671– 696.PubMedCrossRefGoogle Scholar
  95. Holmes K, Levine R, Weaver M (2004) Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 82:454–457.PubMedGoogle Scholar
  96. Jaffar S, Grant AD, Whitworth J, et al. (2004) The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull WHO 82:462–469.PubMedGoogle Scholar
  97. Jeffery HE (1996) Perinatal group B streptococcal infection: a significant public health problem. Semin Neonatal 1:77–89.CrossRefGoogle Scholar
  98. Jeffery HE, Lahra M (1998) Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 101e2. URL: http://www.pediatrics.org/cgi/content/ full/101/1/e2.
  99. Jones J, Kruszon-Moran D, Wilson M, et al. (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154:357–365.PubMedCrossRefGoogle Scholar
  100. Jordon JA (1996) Identification of human parvovirus infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 174;37–42.CrossRefGoogle Scholar
  101. Jumaan AO, Yu O, Jackson LA, et al. (2005) Incidence of herpes-zoster, before and after varicella-vaccination-associated incidence decreases in the incidence of varicella 1992–2002. J Infect Dis 191: 2002–2007.PubMedCrossRefGoogle Scholar
  102. Kimberlin DW, Lin C-Y, Jacobs RF, et al. (2001) Natural history of neonatal herpes simplex virus infections in the Acyclovir era. Pediatrics 108:223–229.PubMedCrossRefGoogle Scholar
  103. Kimberlin DW, Lin Cy, Sanchez PJ, et al. (2003) Effect of ganciclovir therapy on hearing impairment in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143:16–25.PubMedCrossRefGoogle Scholar
  104. Kiss H, Petricevic L, Husslein P (2004) Prospective randomized controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 329:371–375.CrossRefGoogle Scholar
  105. Klebanoff M, Carey C, Hauth J, et al. (2001) Failure of metronidazole to prevent preterm delivery among women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345:487–493.PubMedCrossRefGoogle Scholar
  106. Koch WC (2001) Fifth (human parvovirus) and sixth (herpes virus 6) diseases. Curr Opin Inf Dis 14: 343–356.Google Scholar
  107. Koch WC, Harger JH, Barnstein B, et al. (1998) Sero-logic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 17:489–494.PubMedCrossRefGoogle Scholar
  108. Kotiw M, Zhang G, Daggard G, et al. (2003) Late-onset and recurrent neonatal group B streptococcal disease associated with breast-milk transmission. Pediatr Dev Pathol 6:251–265.PubMedCrossRefGoogle Scholar
  109. Kravetz J, Federman D (2005) Toxoplasmosis in pregnancy. Am J Med 118:212–216.PubMedCrossRefGoogle Scholar
  110. Lahra M, Jeffery HE (2004) A fetal response to chorio-amnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 190:147–151.PubMedCrossRefGoogle Scholar
  111. Laibl V, Sheffield J (2005a) Tuberculosis in pregnancy. Clin Perinatol 32:739–747.CrossRefGoogle Scholar
  112. Laibl V, Sheffield J (2005b) Influenza and pneumonia in pregnancy. Clin Perinatol 32:727–738.CrossRefGoogle Scholar
  113. Lamont R, Duncan S, Mandal D, et al. (2003) Intravagi-nal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 101:516–22.PubMedCrossRefGoogle Scholar
  114. Lamont RF (2005) Vaginal markers of preterm birth. Acta Obstet Gynecol Scand 84:537–538.PubMedCrossRefGoogle Scholar
  115. Le J, Briggs G, McKeown A, et al. (2004) Urinary tract infections during pregnancy. Ann Pharmacotherapy 38:1692–1701.CrossRefGoogle Scholar
  116. Lengeler C (2004) Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database of Systematic Reviews 2:CD000363.Google Scholar
  117. Leviton A, Paneth N, Reuss L, et al. (1999) Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr Res 46:566.PubMedCrossRefGoogle Scholar
  118. Lim W, Macfarlane J, Colthorpe C (2001) Pneumonia and pregnancy. Thorax 56:398–405.PubMedCrossRefGoogle Scholar
  119. Lindsay S, Ansell J, Selman C, et al. (2000) Effect of pregnancy on exposure to malaria mosquitoes. Lancet 355:1972.PubMedCrossRefGoogle Scholar
  120. Lockwood CJ (2002) Predicting premature delivery— no easy task. N Engl J Med 346:282–284.PubMedCrossRefGoogle Scholar
  121. Lopez A, Dieta V, Wilson M, et al. (2000) Preventing congenital toxoplasmosis. MMWR 49 RR-2:59–69.Google Scholar
  122. Maldonado YA (2003) Rubella virus. In: Long SS (ed) Principles and Practice of Pediatric Infectious Diseases, 2nd ed. Churchill Livingstone, New York.Google Scholar
  123. Martin C (2005) The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Eur Respir J 26:162–167.PubMedCrossRefGoogle Scholar
  124. McDonald H, Brocklehurst P, Parsons J (2005) Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews 1: CD000262.Google Scholar
  125. Mertz GJ, Benedetti JK, Selke Sa, et al. (1992) Risk factors for the sexual transmission of genital herpes. Ann Intern Med 116:197–202.PubMedGoogle Scholar
  126. Miller E, Cradock-Watson JE, Pollock TM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2:781–794.PubMedCrossRefGoogle Scholar
  127. Miller E, Cradock-Watson JE, Ridehalgh MK (1989) Outcome of newborn babies given anti-varicella-zoster immunoglobulin after perinatal infection with varicella- zoster virus. Lancet 2:371–373.PubMedCrossRefGoogle Scholar
  128. Miller E, Fairley CK, Cohen BJ, Seng C (1998) Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105:174–178.PubMedGoogle Scholar
  129. Mittal P, Wing D (2005) Urinary tract infections in pregnancy. Clin Perinat 32:749–764.CrossRefGoogle Scholar
  130. Montoya J (2002) Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. Infect Dis 185(suppl 1):s73–82.CrossRefGoogle Scholar
  131. Montoya J, Rosso F (2005) Diagnosis and management of toxoplasmosis. Clin Perinatol 32:705–726.PubMedCrossRefGoogle Scholar
  132. Moodley J, Moodley D (2005) Management of human immunodeficiency virus infection in pregnancy. Best Pract Res Clin Obstet Gynaecol 19:169– 183.PubMedCrossRefGoogle Scholar
  133. Moore M, Schrag S, Schuchat A (2003) Effects of intra-partum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 3:201–13.PubMedCrossRefGoogle Scholar
  134. Morel C, Lauer J, Evans D (2005) Cost effectiveness analysis of strategies to combat malaria in developing countries. Br Med J 331:1299.CrossRefGoogle Scholar
  135. Mylonakis E, Paliou M, Hohmann E, et al. (2002) Liste-riosis during pregnancy: a case series and review of 222 cases. Medicine 81:260–69.PubMedCrossRefGoogle Scholar
  136. Nahmias AJ (2004) Neonatal HSV infection. Part 1: continuing challenges. Herpes 11:33–37.PubMedGoogle Scholar
  137. Nahmias AJ, Lee FK, Beckman-Nahmias S (1990) Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis S69:19–36.Google Scholar
  138. National Institutes of Health (2005) Guidelines for the use of antiretroviral agents in pediatric HIV therapy. http://aidsinfo.nih.gov/ContentFiles/PediatricGuide-lines_PDA.pdf.
  139. Neralla S, Glassroth J (2003) Mycobacterium tuberculosis: the treatment of active disease. Semin Respir Infect 18:292–306.PubMedCrossRefGoogle Scholar
  140. Newman RD, Hailemariam A, Jimma D, et al. (2003) Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year. J Infect Dis 187:1765– 1772.PubMedCrossRefGoogle Scholar
  141. Newnham J, Shub A, Jobe A, et al. (2005) The effects of intra-amniotic injection of periodontopathic lipo-polysaccharides in sheep. Am J Obstet Gynecol 193:313–321.PubMedCrossRefGoogle Scholar
  142. Nicolle L, Bradley S, Colgan R, et al. (2005) Infectious disease society of America guidelines for the diagnosis and treatment of asymptomatic bacteruria in adults. Clin Infect Dis 40:643–654.PubMedCrossRefGoogle Scholar
  143. Nigro G, Bastianon V, Colloridi V, et al. (2004) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of three cases and review. Clin Infect Dis 31:65–69.CrossRefGoogle Scholar
  144. Offenbacher S, Katz V, Fertik G, et al. (1996) Periodon-tal infections as a possible risk factor for preterm low birth weight. J Periodontal 67:1103–1113.Google Scholar
  145. Ogunmodede F, Jones JL, Scheftel J, Kirkland E, Schul-kin J, Lynfield R (2005) Listeriosis prevention knowledge among pregnant women in the USA. Infect Dis Obstet Gynecol 13:11–5.PubMedGoogle Scholar
  146. Olliaro P (2004) Congenital toxoplasmosis. Clin Evidence 12:1058–1061.Google Scholar
  147. Ormerod P (2001) Tuberculosis in pregnancy and the puerperium. Thorax 56:494–499.PubMedCrossRefGoogle Scholar
  148. Orton L, Garner P (2005) Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database of Systematic Reviews 3:CD004912.Google Scholar
  149. Pacora P, Chaiworapongsa T, Maymon E, et al. (2002) Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 11:18– 25.PubMedCrossRefGoogle Scholar
  150. Pastore L, Savitz D, Thorp J (1999) Predictors of urinary tract infection at the first prenatal visit. Epidemiology 10:282–287.PubMedCrossRefGoogle Scholar
  151. Peeling R, Ye H (2004) Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull WHO 82:439–446.PubMedGoogle Scholar
  152. Peipert JF (2003) Genital chlamydial infections. N Engl J Med 349:2424–2430.PubMedCrossRefGoogle Scholar
  153. Petersen E (2004) Malaria chemoprophylaxis: when should we use it and what are the options? Expert Rev Antiinfect Ther 2:119–32.CrossRefGoogle Scholar
  154. Peyron F, Wallon M (2001) Options for the pharmaco-therapy of toxoplasmosis during pregnancy. Exp Opin Pharmacol 2:1269–1274.CrossRefGoogle Scholar
  155. Peyron F, Wallon M, Liou C, et al. (1999) Treatments for toxoplasmosis in pregnancy. Cochrane Database of Systematic Reviews 3:CD001684.Google Scholar
  156. Planche T, Krishna S (2005) The relevance of malaria pathophysiology to strategies of clinical management. Curr Opin Infect Dis 18:369–375.PubMedCrossRefGoogle Scholar
  157. Plotkin SA (2001) Rubella eradication. Vaccine 19: 3311–3319.PubMedCrossRefGoogle Scholar
  158. Polizzotto M (2005) Prevention of sexually transmitted diseases. Clin Fam Prac 7:1–12.CrossRefGoogle Scholar
  159. Preblud SR, Bregman DJ, Vernon LL (1985) Deaths from varicella in infants. Pediatr Infect Dis J 4:503– 507.CrossRefGoogle Scholar
  160. Puopolo K, Madoff L, Eichenwald E (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115:1240–1246.PubMedCrossRefGoogle Scholar
  161. Reef SE, Plotkin S, Cordero JF, et al. (2000) Preparing for elimination of congenital rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 31:85–95.PubMedCrossRefGoogle Scholar
  162. Reynolds DW, Stagno S, Stubbs KG, et al. (1974) Inap-parent congenital cytomegalovirus infection with elevated cord IgM levels; causal relationship with auditory and mental deficiency. N Engl J Med 290:291–296.PubMedGoogle Scholar
  163. Risser W, Bortot A, Benjamins L, et al. (2005) The epidemiology of sexually transmitted infections in adolescents. Semin Pediatr Infect Dis 16:160–167.PubMedCrossRefGoogle Scholar
  164. Robertson SE, Featherstone DA, Gacic-Dobo M (2003) Rubella and congenital rubella syndrome: global update. Pan Am J Public Health 14:306–315.Google Scholar
  165. Rodis JF, Quinn DL, Gary GW Jr, et al. (1990) Management and outcomes of pregnancies complicated by human parvovirus B19 infection: a prospective study. Am J Obst Gynecol 163:1168–1171.Google Scholar
  166. Romero R, Chaiworapongsa T, Espinoza J (2003) Micro-nutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr 133:1668s–1673s.PubMedGoogle Scholar
  167. Romero R, Gomez R, Chaiworapongsa T, et al. (2001) The role of infection in preterm labour and delivery. Paediatr Perinatal Epidemiol 15(suppl 2):41–56.CrossRefGoogle Scholar
  168. Rouse D, Andrews W, Goldenberg R, et al. (1995) Screening and treatment of asymptomatic bacteruria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis. Obstet Gynecol 86:119–123.PubMedCrossRefGoogle Scholar
  169. Rupp R, Stanberry L, Rosenthal S (2004) New biomedi-cal approaches for sexually transmitted infection prevention: vaccines and microbicides. Adolesc Med Clin 15:393–407.PubMedCrossRefGoogle Scholar
  170. Russell P (1979) Inflammatory lesions of the human placenta: I, clinical significance of acute chorioamnionitis. Am J Diagn Gynecol Obstet 1:127–137.Google Scholar
  171. Sachs J, Malaney P (2002) The economic and social burden of malaria. Nature 415:680–685.PubMedCrossRefGoogle Scholar
  172. Saloojee H, Velaphi S, Goga Y, et al. (2004) The prevention and management of congenital syphilis: an overview and recommendations. Bull WHO 82: 424–430.PubMedGoogle Scholar
  173. Schild RL, Bald R, Plath H, et al. (1999) Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 13:161–166.PubMedCrossRefGoogle Scholar
  174. Schleiss MR (2005) Cytomegalovirus infection. www.emedicine.com/MED/topic504.htm.
  175. Schmid G (2004) Policy and practice. Economic and programmatic aspects of congenital syphilis prevention. Bull WHO 82:402–409.Google Scholar
  176. Silver HM (1998) Listeriosis during pregnancy. Obstet Gynecol Surv 53:737–740.PubMedCrossRefGoogle Scholar
  177. Skjoldebrand-Sparre L, Tolfvenstam T, Papadogianna-kis N, et al. (2000) Parvovirus B19 infection: association with third-trimester intrauterine death. Br J Obstet Gynaecol 107:476–480.Google Scholar
  178. Smaill F (1996) Intrapartum antibiotics for group B streptococcal colonization. Cochrane Database of Systematic Reviews 1:CD000115.Google Scholar
  179. Smaill F (2001) Antibiotics for asymptomatic bacter-uria in pregnancy. Cochrane Database of Systematic Reviews 2:CD000490.Google Scholar
  180. Smith K (2002) Congenital tuberculosis: a rare manifestation of a common infection. Curr Opin Infect Dis 15:269–274.PubMedGoogle Scholar
  181. Soper D (2004) Trichomoniasis: Under control or undercontrolled? Am J Obstet Gynecol 190:281–90.PubMedCrossRefGoogle Scholar
  182. Southwick F, Purich D (1996) Mechanisms of disease, Intracellular pathogenesis of listeriosis. N Engl J Med 334:770–776.PubMedCrossRefGoogle Scholar
  183. Spigarelli M, Biro F (2004) Sexually transmitted disease testing: evaluation of diagnostic tests and methods. Adolesc Med Clin 15:287–299.PubMedCrossRefGoogle Scholar
  184. Stagno S, Pass R, Cloud G, et al. (1986) Primary cyto-megalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 256:1904–1908.PubMedCrossRefGoogle Scholar
  185. Steketee R, Nahlen B, Parise M, et al. (2001) The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 64S:28–35.Google Scholar
  186. Steketee RW (2003) Pregnancy, nutrition and parasitic diseases. J Nutr 133:1661S–1667S.PubMedGoogle Scholar
  187. Stevens-Simon C, Sheeder J (2005) Chlamydia tracho-matis: common misperceptions and misunderstandings. J Pediatr Adolesc Gynecol 18:231–243.PubMedCrossRefGoogle Scholar
  188. Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for pneumocys-tis from humans. Emerg Infect Dis 8. http://www.cdc. gov/ncidod/EID/vol8no9/02–0096.htm.Google Scholar
  189. ter Kuile F, Parise M, Verhoeff F, et al. (2004) The burden of co-infection with human immunodefi-ciency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 71(suppl 2):41–54.PubMedGoogle Scholar
  190. Thomsen AC, Morup L, Brogaard Hansen K (1987) Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet 1: 591–593.PubMedCrossRefGoogle Scholar
  191. Trincado DE, Rawlinson WD (2001) Congenital and perinatal infections with cytomegalovirus. J Paediatr Child Health 37:187–192.PubMedCrossRefGoogle Scholar
  192. U.S. Department of Health and Human Services (2000) Blueprint for action on breastfeeding. http://www. womenshealth.gov/Breastfeeding/bluprntbk2.pdf.
  193. van Geertruyden J-P, Thomas F, Erhart A, et al. (2004) The contribution of malaria in pregnancy to perinatal mortality. Ann Trop Med Hyg 71(suppl 2):35– 40.Google Scholar
  194. Vazquez JC, Villar J (2003) Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database of Systematic Reviews 4:CD002256.Google Scholar
  195. Villar J, Widmer M, Lyon-Rochelle MT, et al. (2000) Duration of treatment for asymptomatic bacteruria during pregnancy. Cochrane Database of Systematic Reviews 2:CD000491.Google Scholar
  196. Volmink J, Garner P (2003) Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews 1:CD003343.Google Scholar
  197. Wagner HU, Van Dyck E, Roggan E, et al. (1994) Sero-prevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS 5:322–327.Google Scholar
  198. Weiss HA, Buve A, Robinson NJ, et al. (2001) Study group on the heterogeneity of HIV epidemics in African Cities. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 15(suppl 4):S97–S108.PubMedCrossRefGoogle Scholar
  199. White DO, Fenner FJ (1994a) Cytomegalovirus in Her-pesviridae In: Medical Virology, 4th ed. Academic Press, San Diego, pp. 334–341.Google Scholar
  200. White DO, Fenner FJ (1994b) Herpes simplex viruses in Herpesviridae. In: Medical Virology, 4th ed. Academic Press, San Diego, pp. 323–330.Google Scholar
  201. White DO, Fenner FJ (1994c) Human immunodefi-ciency virus in Retroviridae In: Medical Virology, 4th ed. Academic Press, San Diego, pp. 538–561.Google Scholar
  202. White DO, Fenner FJ (1994d) Parvoviridae In: Medical Virology, 4th ed. Academic Press, San Diego, pp. 285–293.Google Scholar
  203. White DO, Fenner FJ (1994e) Varicella-Zoster virus in Herpesviridae In: Medical Virology, 4th ed. Academic Press, San Diego, pp. 333–334.Google Scholar
  204. Whitely RJ (2000) Varicella-zoster virus. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, New York, pp. 1580–1586.Google Scholar
  205. Whitely RJ, Corey L, Arvin A, et al. (1988) Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 158:109–116.Google Scholar
  206. Workowski K, Levine W, Wasserheit J (2002) U.S. Centers for disease control and prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unify clinical and public health practice. Ann Intern Med 137:e255–262.Google Scholar
  207. World Health Organization (2004a) AIDS Epidemic update. http://.whqlibdoc.who.int/unaids/2004/a 62410.
  208. World Health Organization (2004b) A strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. Brazzawille: WHO Regional Office for Africa.Google Scholar
  209. WHO/UNAIDS/LSHTM (2001) Herpes simplex virus type 2 programmatic and research priorities in developing countries. Report of a WHO/UNAIDS/LSHTM Workshop 2001. http://www.who.int/docstore/hiv/ herpes meeting/.
  210. Yaegashi N, Niinuma T, Chisaka H, et al. (1999) Sero-logic study of human parvovirus B19 in pregnancy in Japan. J Infect 38:30–35.PubMedCrossRefGoogle Scholar
  211. Yaegashi N, Okamura K, Yajima A, et al. (1994) The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. J Perinat Med 22:159– 163.PubMedCrossRefGoogle Scholar
  212. Yoon B, Romero R, Park J, et al. (2000) The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 183:1124–1129.PubMedCrossRefGoogle Scholar
  213. Yost N, Bloom S, Richey S, et al. (2000) An appraisal of treatment guidelines for antepartum community-acquired pneumonia. Am J Obstet Gynecol 183: 131–135.PubMedGoogle Scholar
  214. Young G, Jewell D (2001) Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database of Systematic Reviews 4:CD000225.Google Scholar
  215. Young NS, Brown KE (2004) Mechanisms of disease: parvovirus B19. N Engl J Med 350:586–597.PubMedCrossRefGoogle Scholar
  216. Yudin MH (2005) Bacterial vaginosis in pregnancy: diagnosis, screening and management. Clin Perinatol 32:617–627.PubMedCrossRefGoogle Scholar
  217. Zeltser R, Kurban A (2004) Syphilis. Clin Dermatol 22:461–468.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  • Heather E. Jeffery
    • 1
  • Monica M. Lahra
    • 1
  1. 1.Department of Neonatal Medicine, Royal Prince Alfred Newborn CareRoyal Prince Alfred Hospital and the University of SydneyCamperdownAustralia

Personalised recommendations